Heart failure Clinical Trials in Dothan, AL
As of June 2026, 1 paid clinical trial is recruiting for Heart failure in Dothan, Alabama. Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Dothan
Filter results
1 clinical trial for Heart failure
·Clear filters·↓ Download CSVAbout research studies in Dothan
Dothan has approximately 44 recruiting research studies across a wide range of therapeutic areas. Alabama hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Dothan
Researchers run research studies in Dothan, AL at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| SEC Clinical Research | Atrial Fibrillation (AF), Healthy, Heart Failure With Mildly Reduced Ejection Fraction | 5 |
| Trinity Research Group | Arteriovenous Fistula, Chronic Kidney Disease, Diabetes | 5 |
| Digestive Health Specialists | Obesity or Overweight, Crohn's Disease, Ulcerative Colitis | 4 |
| Glaukos Investigative Site | Glaucoma, Persistent Corneal Epithelial Defect, Progressive Keratoconus | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Digestive Health Specialsits | Crohn's Disease, Ulcerative Colitis | 2 |
| Harmonex Neuroscience Research | Autism Spectrum Disorder, Major Depressive Disorder | 2 |
| Alkermes Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Alkermes Investigator Site | Bipolar I Disorder, Schizophrenia | 1 |
| Clinical Study Center | Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease | 1 |
| Dothan Hematology & Oncology | Castration-Resistant Prostate Cancer (CRPC), Cervical Cancer, Colorectal Cancer | 1 |
| Dothan Hematology and Oncology | Breast Cancer, Metastatic Breast Cancer | 1 |
| Harmonex | Major Depressive Disorder | 1 |
| Local Institution - 0036 | Irritability Associated With Autism Spectrum Disorder | 1 |
| SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS | Chronic Obstructive Pulmonary Disease | 1 |
| SEC Clinical Research, LLC | Chronic Obstructive Pulmonary Disease | 1 |
| Sec Clinical Research - East - Dothan - Graceland | Idiopathic Pulmonary Fibrosis | 1 |
| Site 7173 | Treatment-resistant Depression (TRD) | 1 |
| Trinity Research Group, LLC | Cataract, Posterior Capsule Opacification, Presbyopia | 1 |
| XCancer Research Network/Dothan Hematology & Oncology | Advanced Cancer, Lung Cancer (NSCLC), Lung Cancer Metastatic | 1 |
| XCancer/Dothan Hematology & Oncology - 1114 | Non Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Dothan (2026)
Recruiting trials in Dothan grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (7 active studies)
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · Phase 3 · AstraZeneca
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors · Phase 1, Phase 2 · Radiopharm Theranostics, Ltd
Diabetes & metabolic (6 active studies)
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study · Phase 3 · Eli Lilly and Company
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Mental health & behavior (4 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients · Phase 3 · Intra-Cellular Therapies, Inc.
Cardiovascular (4 active studies)
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Eye & vision (3 active studies)
- Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant · Phase 3 · Glaukos Corporation
- A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease · Phase 3 · AbbVie
Common conditions studied in Dothan
- Crohn's Disease (4 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atrial Fibrillation (AF) (2 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Bipolar I Disorder (2 active studies). Recruiting Bipolar I Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer, Early Breast Cancer (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Obstructive Pulmonary Disease (2 active studies). COPD research evaluates biologic therapies, triple-inhaler combinations, and new anti-inflammatory agents to reduce exacerbations.
- Irritability Associated With Autism Spectrum Disorder (2 active studies). Recruiting Irritability Associated With Autism Spectrum Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Dothan
- AbbVie
- AstraZeneca
- Glaukos Corporation
- Hoffmann-La Roche
- Akero Therapeutics, Inc
Local regulations and guidelines
Clinical trials in Alabama are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Alabama research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Dothan. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Dothan
Hipa.ai aggregates every recruiting study in Dothan from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Dothan?
There are approximately 44 recruiting clinical trials in Dothan, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Dothan pay participants?
Most recruiting trials in Dothan compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Dothan?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Dothan?
The most common conditions under active study in Dothan include Crohn's Disease (4), Atrial Fibrillation (AF) (2), Bipolar I Disorder (2), Breast Cancer, Early Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Dothan?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dothan on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Dothan?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Dothan?
Recruiting research sites in Dothan include SEC Clinical Research, Trinity Research Group, Digestive Health Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Dothan right now?
The largest active categories in Dothan are Cancer & tumors (7), Diabetes & metabolic (6), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.